Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02323802
Other study ID # AMI-Obesity
Secondary ID
Status Recruiting
Phase N/A
First received December 18, 2014
Last updated December 18, 2014
Start date July 2013
Est. completion date December 2015

Study information

Verified date December 2014
Source IRCCS Policlinico S. Matteo
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

Results after interventions on lifestyle in the secondary prevention of ischemic heart disease are not always consistent, and the Guidelines multidisciplinary measures aren't easily achievable.

Therefore, the purpose of this research project is the identification of an interventional approach to effective secondary prevention and realistic feasibility, in a field of multifactorial risk. The study is open to patients who totaled a double chronic disease, obesity/overweight and coronary heart disease, and who experienced a first event of ischemic cardiac infarction (AMI). The aim is to evaluate the effectiveness of a group educational intervention in a sample of overweight and obese patients (BMI > 24.9) incurred in a first episode of acute myocardial infarction (non-STEMI and STEMI), comparing with the classic approach of prescriptive diet therapy.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date December 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

Subjects of both sexes and age = of 18 years consecutively admitted to the Coronary Unit of IRCCS Foundation Policlinico S. Matteo, at first episode of STEMI or non-STEMI AMI, with BMI greater than 24.9.

Exclusion Criteria:

Patients who can not provide informed consent (because illiterate or with significant language barrier or severe deficit/cognitive decays). Subjects with diseases and/or disabling organ damage. Subjects affected by active neoplasm. Individuals who have submitted arhythmic complications in acute and/or heart failure, or people referring to post-AMI residential rehabilitation. Subjects that are carriers of severe psychiatric disorders diagnosed by DSM-V -TR.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
educational group intervention

prescriptive diet


Locations

Country Name City State
Italy Cardiology department Pavia
Italy Internal Medicine Department, Clinica Medica II, IRCCS San Matteo Foundation Pavia PV

Sponsors (1)

Lead Sponsor Collaborator
IRCCS Policlinico S. Matteo

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary reduction of body weight The proportion of subjects with a 10% reduction in body weight at 6 months 6 months No
Secondary Reduction of reinfarction and revascularization 1 year No
Secondary general and specific mortality relative risk of death from all causes and from ischemic heart disease (no. of overall deaths and cardiovascular causes). 1 year No
Secondary quality of life quality of life (assessed by SF-36 questionnaire at baseline and 6 months after infarction). 6 months No